Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pharmaceutical Technology
11d
CD30 by Wuhan Bio-Raid Biotechnology for T-Cell Lymphomas: Likelihood of Approval
CD30 is under clinical development by Wuhan Bio-Raid Biotechnology and currently in Phase I for T-Cell Lymphomas.
3d
WestGene Biopharma Presents Groundbreaking mRNA Vaccine Data at ESMO 2024
WestGene Biopharma, a leading innovator in mRNA therapeutics, presented the latest clinical data for its EBV-positive tumour ...
Pharmaceutical Technology
11d
CD30 by Wuhan Bio-Raid Biotechnology for T-Cell Leukemia: Likelihood of Approval
CD30 is under clinical development by Wuhan Bio-Raid Biotechnology and currently in Phase I for T-Cell Leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Cancels appearance w/ Duda
FCC chair denies Trump call
Boy kills bear, saves father
Hold campaign event in MI
Ban called for in TX schools
To get a second moon
Families lose appeal
Rally attendees injured
PGA welcomes LIV players
Man charged for threats
Makes MLB history
Existing home sales drop
Collapse hazard recall
To receive Holbrooke award
Vows to remain in race
Overdose deaths drop in US
US healthcare system falls
NYC subway joyride arrest
Retires after 17 seasons
FTC on privacy controls
Israel strikes Hezbollah
Dow, S&P hit record highs
Hails economic progress
US jobless claims fall
Joins Motion Picture Assn.
Brazil threatens daily fines
Deal to build new arena
160M euros to Ukraine
EU warns Apple
UN backs Palestine
COVID, Wuhan market link
Gun case sentencing delay
Feedback